BFRA
Income statement / Annual
Last year (2020), Biofrontera AG's total revenue was $30.35 M,
a decrease of 2.94% from the previous year.
In 2020, Biofrontera AG's net income was -$13.02 M.
See Biofrontera AG,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
Operating Revenue |
$30.35 M |
$31.27 M |
$21.11 M |
$12.03 M |
$6.13 M |
$4.14 M |
$3.10 M |
$3.11 M |
$3.43 M |
$515,296.00 |
Cost of Revenue |
$3.54 M
|
$4.88 M
|
$4.45 M
|
$1.72 M
|
$1.65 M
|
$1.24 M
|
$1.12 M
|
$1.60 M
|
$1.51 M
|
$444,884.00
|
Gross Profit |
$26.81 M
|
$26.39 M
|
$16.66 M
|
$10.31 M
|
$4.48 M
|
$2.90 M
|
$1.98 M
|
$1.51 M
|
$1.92 M
|
$70,412.00
|
Gross Profit Ratio |
0.88
|
0.84
|
0.79
|
0.86
|
0.73
|
0.7
|
0.64
|
0.49
|
0.56
|
0.14
|
Research and Development Expenses |
$4.79 M
|
$4.64 M
|
$4.43 M
|
$4.23 M
|
$4.64 M
|
$6.20 M
|
$4.53 M
|
$3.19 M
|
$1.38 M
|
$1.40 M
|
General & Administrative Expenses |
$9.15 M
|
$16.28 M
|
$12.96 M
|
$3.10 M
|
$2.85 M
|
$2.76 M
|
$3.12 M
|
$5.46 M
|
$4.09 M
|
$0.00
|
Selling & Marketing Expenses |
$20.48 M
|
$28.86 M
|
$17.74 M
|
$16.92 M
|
$8.76 M
|
$4.17 M
|
$3.85 M
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$29.63 M
|
$45.13 M
|
$30.71 M
|
$20.02 M
|
$11.62 M
|
$6.93 M
|
$6.97 M
|
$5.46 M
|
$4.09 M
|
$0.00
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.04 M
|
Operating Expenses |
$34.42 M
|
$49.77 M
|
$35.13 M
|
$24.24 M
|
$16.26 M
|
$13.13 M
|
$11.51 M
|
$8.65 M
|
$5.48 M
|
$4.44 M
|
Cost And Expenses |
$37.96 M
|
$54.64 M
|
$39.59 M
|
$25.96 M
|
$17.91 M
|
$14.37 M
|
$12.62 M
|
$10.25 M
|
$6.98 M
|
$4.89 M
|
Interest Income |
$411,000.00
|
$127,000.00
|
$24,000.00
|
$38,000.00
|
$2,935.14
|
$9,225.68
|
$190,294.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$3.08 M
|
$2.71 M
|
$1.78 M
|
$1.13 M
|
$1.21 M
|
$1.17 M
|
$1.29 M
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$5.33 M
|
$3.16 M
|
$754,000.00
|
$884,000.00
|
$830,779.00
|
$811,681.00
|
$811,005.00
|
$742,133.00
|
$643,290.00
|
$361,821.00
|
EBITDA |
-$4.28 M |
$804,000.00 |
-$16.73 M |
-$14.09 M |
-$8.54 M |
-$9.22 M |
-$8.62 M |
-$7.32 M |
-$3.46 M |
-$4.28 M |
EBITDA Ratio |
-0.14
|
0.03
|
-0.79
|
-1.17
|
-1.39
|
-2.23
|
-2.78
|
-2.35
|
-1.01
|
-8.31
|
Operating Income Ratio |
-0.25
|
-0.75
|
-0.88
|
-1.16
|
-1.92
|
-2.47
|
-3.08
|
-2.29
|
-1.04
|
-8.49
|
Total Other Income/Expenses Net |
-$5.09 M
|
$18.60 M
|
-$791,000.00
|
-$2.17 M
|
$1.20 M
|
-$972,456.91
|
-$1.19 M
|
-$928,877.91
|
-$550,161.46
|
-$270,092.52
|
Income Before Tax |
-$12.70 M
|
-$4.78 M
|
-$19.27 M
|
-$16.10 M
|
-$10.58 M
|
-$11.20 M
|
-$10.72 M
|
-$8.07 M
|
-$4.10 M
|
-$4.64 M
|
Income Before Tax Ratio |
-0.42
|
-0.15
|
-0.91
|
-1.34
|
-1.73
|
-2.71
|
-3.46
|
-2.59
|
-1.2
|
-9.01
|
Income Tax Expense |
$326,000.00
|
$2.58 M
|
-$10.39 M
|
-$1.04 M
|
$2.41 M
|
$196,094.00
|
$95,592.00
|
-$928,877.91
|
$15,262.00
|
-$270,092.52
|
Net Income |
-$13.02 M
|
-$7.64 M
|
-$8.88 M
|
-$16.10 M
|
-$10.58 M
|
-$11.20 M
|
-$10.72 M
|
-$8.07 M
|
-$4.12 M
|
-$4.64 M
|
Net Income Ratio |
-0.43
|
-0.24
|
-0.42
|
-1.34
|
-1.73
|
-2.71
|
-3.46
|
-2.59
|
-1.2
|
-9.01
|
EPS |
-0.47 |
-0.33 |
-0.4 |
-0.78 |
-0.66 |
-0.78 |
-0.8 |
-0.59 |
-0.44 |
-0.69 |
EPS Diluted |
-0.47 |
-0.33 |
-0.4 |
-0.78 |
-0.66 |
-0.78 |
-0.8 |
-0.59 |
-0.44 |
-0.69 |
Weighted Average Shares Out |
$27.83 M
|
$22.95 M
|
$22.44 M
|
$20.53 M
|
$16.03 M
|
$14.34 M
|
$13.47 M
|
$13.74 M
|
$9.29 M
|
$6.71 M
|
Weighted Average Shares Out Diluted |
$27.83 M
|
$22.95 M
|
$22.44 M
|
$20.53 M
|
$16.03 M
|
$14.34 M
|
$13.47 M
|
$13.74 M
|
$9.29 M
|
$6.71 M
|
Link |
|
|
|
|
|
|
|
|
|
|